Menora Mivtachim Holdings’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Menora Mivtachim Holdings’s Portfolio VBIV Stock Details VBIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-175,329	Closed	-$9.84M	–	83
2019 Q1	$9.84M	Hold	175,329	–	–	0.26%	60
2018 Q4	$8.42M	Buy	175,329 +60,000	+52%	+$3.29M	0.24%	69
2018 Q3	$8.37M	Hold	115,329	–	–	0.23%	78
2018 Q2	$9.52M	Buy	115,329 +24,824	+27%	+$2.4M	0.27%	83
2018 Q1	$9.5M	Buy	90,505 +2,040	+2%	+$243K	0.3%	77
2017 Q4	$11.3M	Buy	+88,465	New	+$10.9M	0.44%	66

Other funds holding VBIV

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

GAI

General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return

HIIFS

Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Menora Mivtachim Holdings's VBIV Position: Q2 2019 in Review

Menora Mivtachim Holdings sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q2 2019, closing a stake of 175,329 shares — an estimated $9.84M sold.

Menora Mivtachim Holdings first reported a position in VBIV in Q4 2017 and held it in 6 quarters. The position peaked at $11.3M in Q4 2017. 56 funds tracked by Wall St. Rank hold VBIV as of Q2 2019.

Menora Mivtachim Holdings reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q2 2019 after selling out during the quarter.
Menora Mivtachim Holdings sold 175,329 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q2 2019, an estimated $9.84M.
Menora Mivtachim Holdings first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q4 2017 and held it in 6 quarters.
Menora Mivtachim Holdings's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $11.3M in Q4 2017.
56 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q2 2019.

Based on Menora Mivtachim Holdings's 13F filing for Q2 2019, filed 1 Aug 2019.